Nancy Hong

Dr. Nancy Hong is a managing director at the life science venture capital firm RiverVest Venture Partners. There she focuses on investing in early-stage biopharmaceutical and medical device companies addressing serious unmet medical needs. Currently, Nancy is a member of the Board of Directors at Scout Bio and Xilio Therapeutics.

Previously, Nancy was an investment professional at BioMed Ventures and Forward Ventures. Nancy started her career as a bioinformatics scientist at Phenomix, a startup biotech company in San Diego.

Trained in the areas of immunology and oncology, Nancy earned a B.S. with honors in Biology from the California Institute of Technology and a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley. She conducted postdoctoral research at the University of California, San Francisco, as a fellow of the Leukemia & Lymphoma Society.

Nancy thanks her parents for sharing their love of classical music. She lives in Del Mar with her husband and son.